Oxford Biomedica

Email address and contacts

Oxford Biomedica company description

Oxford Biomedica (LSE: OXB) is an innovative leading viral vector specialist focused on delivering life changing therapies to patients. Based in Oxfordshire (UK) and greater Boston (US), we work across key viral vector delivery systems including those based on lentivirus, adeno-associated virus (AAV) and adenovirus, providing innovative solutions to meet our partner’s process development, analytical development, and manufacturing needs. Our well-established and industry leading lentiviral vector platform, LentiVector® platform, is used to develop product candidates in-house, before seeking partners to take the products into clinical trials. Our platform, IP, patents, and know-how, along with our 25 plus years of expertise in applying its lentiviral vector technology, has taken us from pioneers in the field to the sector leader we are today. OXB Solutions, our US based best-in-class AAV manufacturing and innovation business is raising the bar in AAV development and manufacturing solutions. Offering full scope process development and GMP operations using a commercially ready ‘plug and play’ platform. The execution and data speak for itself: - HEK293 suspension process scaled up from 2L to 2000L - Dual plasmid system with optimised transfection demonstrating E15 vg/L in bioreactors - Demonstrated >90% fully intact vector - Analytical toolbox with 40+ methods developed and qualified in-house - Delivered greater than 45 500L GMP batches in the last three years - 6 successful IND regulatory filings We drive credible science and innovation to help realise incredible results, making us the ideal cell and gene therapy vector partner. Discover how by visiting our website.

  • Employee count


  • Industry

  • Headquarters address

    Windrush Court Oxfordshire Oxford

  • Country

    United Kingdom of Great Britain and Northern Ireland

  • Company website


Key Employees

Scientist IV
Find Email
Harriet Cutter
HR Business Partner
Katarzyna Machowiak
Talent Acquisition Administrator
Harsha Reddy
Principal Scientist (Team Lead) - Cell and Gene Therapy Late Stage Development
Daniel Clarkson
Production Technician
Paul Blake
Chief Development Officer
Adrian Jacobs
Special Projects Lead
Sign up to open these and 5 more emails in Oxford Biomedica
Message error line

Oxford Biomedica competitors and alternatives

770 employees
Ascendis Pharma
757 employees
Adaptive Biotechnologies Corp.
754 employees
Ambry Genetics
702 employees
693 employees
688 employees
View all competitors

Recently updated team members of Oxford Biomedica

Diane Varley
Principal Scientist
Ellen Montilla
Business Continuity & Risk Management Lead
Léa Ledaine
Cell culture scientist
Tina Mistry
Scientist IV
Alysa Hawkins
Clinical Analysis Scientist Grade 4
Yasmeen Saqlain
ASG Scientist
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

50 Free emails every month

Add to Chrome

500+ reviews 60,000+ users

Ready to get started?

Try GetProspect email finder for free, and explore all the tools you need to scale your business

Real data
No credit card needed
Leave any time
Find Emails